BioPharma Dive October 9, 2024
Gwendolyn Wu

The startup, which is building a database of biological interactions found in nature, also secured $60 million in funding from a group of life sciences and tech investors.

Basecamp Research, a biotechnology startup focused on artificial intelligence, has raised $60 million in funding and signed a multi-year collaboration with the Broad Institute of MIT and Harvard.

The London-based company said Wednesday that it will work with the lab of David Liu, a prominent gene editing researcher and biotech entrepreneur, to advance new types of “programmable” genetic medicines. The collaboration aims to invent “novel fusion proteins and other large molecules” that might enable those medicines, it said in a statement. Basecamp did not provide specifics.

The collaboration and funding are steps...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma / Biotech, Technology, Trends
Generative AI Is Helping To Clear Up Brain Fog
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever

Share This Article